Alcoholic liver disease–pathophysiological aspects and risk factors
Background Alcoholic liver disease has a known aetiology but a complex and incompletely
known pathogenesis. It is an extremely common disease with significant morbidity and …
known pathogenesis. It is an extremely common disease with significant morbidity and …
Identification and management of alcohol withdrawal syndrome
A Mirijello, C D'Angelo, A Ferrulli, G Vassallo… - Drugs, 2015 - Springer
Symptoms of alcohol withdrawal syndrome (AWS) may develop within 6–24 h after the
abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from …
abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from …
Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options
Alcohol-use-disorders (AUDs) afflict 1–3% of elderly subjects. The CAGE, SMAST-G, and
AUDIT are the most common and validated questionnaires used to identify AUDs in the …
AUDIT are the most common and validated questionnaires used to identify AUDs in the …
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled …
G Addolorato, L Leggio, A Ferrulli, S Cardone… - The Lancet, 2007 - thelancet.com
Background Intervention to achieve alcohol abstinence represents the most effective
treatment for alcohol-dependent patients with liver cirrhosis; however, anticraving drugs …
treatment for alcohol-dependent patients with liver cirrhosis; however, anticraving drugs …
Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study
Aims: The γ-aminobutyric acid (GABAB) receptor agonist, baclofen, has recently been
shown to reduce alcohol intake in alcohol-preferring rats and alcohol consumption and …
shown to reduce alcohol intake in alcohol-preferring rats and alcohol consumption and …
Voluntary disclosure of Sustainable Development Goals in mandatory non‐financial reports: The moderating role of cultural dimension
Abstract The Directive 2014/95/EU represents one of the main innovations introduced by the
European Commission to encourage large companies to disclose their contribution to …
European Commission to encourage large companies to disclose their contribution to …
Ability of baclofen in reducing alcohol craving and intake: II—Preliminary clinical evidence
Background: Accumulating evidence shows the efficacy of the γ‐aminobutyric acid (GABAB)
receptor agonist baclofen in reducing alcohol intake in rats, but no studies have been …
receptor agonist baclofen in reducing alcohol intake in rats, but no studies have been …
Enhancing environmental information transparency through corporate social responsibility reporting regulation
This research aims to contribute to the scientific debate about the lack of interlinkages
between mandatory non‐financial reporting and sustainable business models. For our …
between mandatory non‐financial reporting and sustainable business models. For our …
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam
PURPOSE: Benzodiazepines are the drugs of choice in the treatment of alcohol withdrawal
syndrome (AWS). Recent data have shown that baclofen may reduce AWS symptoms. At …
syndrome (AWS). Recent data have shown that baclofen may reduce AWS symptoms. At …
Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial
G Addolorato, L Leggio, A Ferrulli… - Alcohol and …, 2011 - academic.oup.com
Aims: To explore the effect of baclofen in a dose of 20 mg three times per day, compared
with the already studied dose of 10 mg three times per day, in the treatment of alcohol …
with the already studied dose of 10 mg three times per day, in the treatment of alcohol …